An in-depth look to NOVONESIS A/S (NOVOZYMES A/S) operating, investing, and financing activities

NZM2 free cash flow for Q1 25 is 60.95 M EUR. For 2024, NZM2 free cash flow was 679.67 M EUR and operating cash flow was 1.02 B EUR.